Natural products in drug discovery and development. 1997

G M Cragg, and D J Newman, and K M Snader
Natural Products Branch, National Cancer Institute, Frederick Cancer Research and Development Center, Maryland 21702-1201, USA.

UI MeSH Term Description Entries
D010600 Pharmacology The study of the origin, nature, properties, and actions of drugs and their effects on living organisms. Pharmacologies
D010946 Plants, Medicinal Plants whose roots, leaves, seeds, bark, or other constituent parts possess therapeutic, tonic, purgative, curative or other pharmacologic attributes, when administered to man or animals. Herbs, Medicinal,Medicinal Herbs,Healing Plants,Medicinal Plants,Pharmaceutical Plants,Healing Plant,Herb, Medicinal,Medicinal Herb,Medicinal Plant,Pharmaceutical Plant,Plant, Healing,Plant, Medicinal,Plant, Pharmaceutical,Plants, Healing,Plants, Pharmaceutical
D012106 Research Critical and exhaustive investigation or experimentation, having for its aim the discovery of new facts and their correct interpretation, the revision of accepted conclusions, theories, or laws in the light of newly discovered facts, or the practical application of such new or revised conclusions, theories, or laws. (Webster, 3d ed) Research Priorities,Laboratory Research,Research Activities,Research and Development,Activities, Research,Activity, Research,Development and Research,Priorities, Research,Priority, Research,Research Activity,Research Priority,Research, Laboratory
D017277 Drug Approval Process that is gone through in order for a drug to receive approval by a government regulatory agency. This includes any required pre-clinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance of the drug. Drug Approval Process,New Drug Approval,Food and Drug Administration Drug Approval,Food and Drug Administration Drug Approval Process,New Drug Approval Process,Approval Process, Drug,Approval Processes, Drug,Approval, Drug,Approval, New Drug,Approvals, Drug,Approvals, New Drug,Drug Approval Processes,Drug Approval, New,Drug Approvals,Drug Approvals, New,New Drug Approvals,Process, Drug Approval,Processes, Drug Approval

Related Publications

G M Cragg, and D J Newman, and K M Snader
September 2021, Phytotherapy research : PTR,
G M Cragg, and D J Newman, and K M Snader
November 2022, National science review,
G M Cragg, and D J Newman, and K M Snader
January 2000, Ernst Schering Research Foundation workshop,
G M Cragg, and D J Newman, and K M Snader
October 2008, Drug discovery today,
G M Cragg, and D J Newman, and K M Snader
July 2006, Journal of industrial microbiology & biotechnology,
G M Cragg, and D J Newman, and K M Snader
August 2009, Nature reviews. Drug discovery,
G M Cragg, and D J Newman, and K M Snader
January 2005, Methods in molecular medicine,
G M Cragg, and D J Newman, and K M Snader
December 2004, Evidence-based complementary and alternative medicine : eCAM,
G M Cragg, and D J Newman, and K M Snader
March 2020, Molecules (Basel, Switzerland),
G M Cragg, and D J Newman, and K M Snader
July 2007, Expert opinion on drug discovery,
Copied contents to your clipboard!